Submission for applications to the XOVA program has been extended to January 22, 2018.
Initiatives based in any country are warmly welcomed.
Proposed initiatives must demonstrate a clear impact on improving the quality of eye care, as well as long-term viability and sustainability, with outcomes projected within two years. Applicants must provide details of projects that have already been designed and planned. Initiatives must be at a relatively advanced stage, simply requiring the XOVA funding grant in order to provide education with sustainable impact, and/or innovation in clinical practice.
For more information on applying for XOVA, please see our frequently asked questions (FAQ) page.
If you have any questions that are not answered in the FAQ please contact us via email at XOVA@amp-health.ch.
Data Privacy Statement: When you apply to XOVA, you accept that the Sponsors (Novartis Pharma AG, located in Basel Switzerland), AMP Health located in Zürich, Switzerland (who manage the XOVA program), and the XOVA judging faculty (ophthalmology experts located in countries around the world) will use the information you provide on your application to select the XOVA winners, and to contact successful applicants. Once the program is concluded for a particular year, if you have not been selected, your personal information will be deleted. By submitting this application you permit Novartis Pharma AG, AMP Health, and the judging faculty to use your personal information as described, and to transfer the information between themselves as required for the purposes of the program.